Biomedical Engineering Reference
In-Depth Information
96. European Union Decision 2002/657/EC (17/8/2002) (2002) Off J Eur Commun 221:8-36
97. Peters FT (2006) Method validation using LC-MS. In: Polettini A (ed) Applications of
LC-MS in toxicology, 1st edn. Pharmaceutical, London
98. Moraes MO, Lerner FE, Corso G et al (1999) Fluoxetine bioequivalence study: quantification
of fluoxetine and norfluoxetine by liquid chromatography coupled to mass spectrometry. J
Clin Pharmacol 39:1053-1061
99. Li C, Ji Z, Nan F et al (2002) Liquid chromatography/tandem mass spectrometry for the
determination of fluoxetine and its main active metabolite norfluoxetine in human plasma
with deuterated fluoxetine as internal standard. Rapid Commun Mass Spectrom
16:1844-1850
100. Sutherland FC, Badenhorst D, de Jager AD et al (2001) Sensitive liquid chromatographic-
tandem mass spectrometric method for the determination of fluoxetine and its primary active
metabolite norfluoxetine in human plasma. J Chromatogr A 914:45-51
101. Massaroti P, Cassiano NM, Duarte LF et al (2005) Validation of a selective method for deter-
mination of paroxetine in human plasma by LC-MS/MS. J Pharm Pharm Sci 8:340-347
102. Zhu Z, Neirinck L (2002) High-performance liquid chromatography-mass spectrometry
method for the determination of paroxetine in human plasma. J Chromatogr B Anal Technol
Biomed Life Sci 780:295-300
103. Qin F, Li N, Qin T et al (2010) Simultaneous quantification of venlafaxine and
O-desmethylvenlafaxine in human plasma by ultra performance liquid chromatography-tan-
dem mass spectrometry and its application in a pharmacokinetic study. J Chromatogr B Anal
Technol Biomed Life Sci 878:689-694
104. Rajasekhar D, Kumar IJ, Venkateswarlu P (2009) Rapid high-performance liquid chromatog-
raphy-tandem mass spectrometry method for simultaneous measurement of venlafaxine and
O-desmethylvenlafaxine in human plasma and its application in comparative bioavailability
study. Biomed Chromatogr 23:1300-1307
105. Singh SS, Shah H, Gupta S et al (2004) Liquid chromatography-electrospray ionisation mass
spectrometry method for the determination of escitalopram in human plasma and its applica-
tion in bioequivalence study. J Chromatogr B Anal Technol Biomed Life Sci 811:209-215
106. Xu P, Li HD, Chen BM et al (2008) Determination of mianserin in human plasma by high
performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-ESI/
MS): application to a bioequivalence study in Chinese volunteers. J Pharm Biomed Anal
47:994-999
107. Chauhan B, Rani S, Guttikar S et al (2005) Analytical method development and validation of
mianserin hydrochloride and its metabolite in human plasma by LC-MS. J Chromatogr B
Anal Technol Biomed Life Sci 823:69-74
108. Gutteck U, Rentsch KM (2003) Therapeutic drug monitoring of 13 antidepressant and five
neuroleptic drugs in serum with liquid chromatography-electrospray ionization mass spec-
trometry. Clin Chem Lab Med 41:1571-1579
109. Castaing N, Titier K, Receveur-Daurel M et al (2007) Quantification of eight new antidepres-
sants and five of their active metabolites in whole blood by high-performance liquid chroma-
tography-tandem mass spectrometry. J Anal Toxicol 31:334-341
110. Fleishaker JC, Mucci M, Pellizzoni C et al (1999) Absolute bioavailability of reboxetine
enantiomers and effect of gender on pharmacokinetics. Biopharm Drug Dispos 20:53-57
